Senior Economist at The Office of Health Economics (OHE)
Dr Bernarda Zamora joined OHE in 2015. She has participated in several projects involving econometric and qualitative research. Her main interests focus on the impact of HTA on access and financing of health. She has worked on frameworks for assessing the potential value contribution of medical diagnostics, access to orphan drugs, cost-effectiveness, and a variety of research and consulting projects.
Prior to joining OHE in 2015, Bernarda has worked in Spanish and British academia and international organisations. She holds a PhD in Economics from the University Carlos III of Madrid and a Certificate in Quantitative Finance from Fitch Learning.
2 blogs from the author
Posted on 03.09.2020
COVID-19 & diagnostics: lessons on how to extract value from data
This is the second in a two-part series. Read part one. The link between clinical and social aspects of COVID-19 raises the question of what type of data are needed to manage the COVID-19 surge and better absorb shocks that may be caused by future pandemics. We believe clinical patient level data are essential given […]
Posted on 27.08.2020
COVID-19 & diagnostics: the value of ‘test, test, test’
The power of diagnostics information (VODI) to public health and society was a topic of keen interest even before the COVID-19 outbreak. The pandemic offers us fresh lessons on how health systems can harness this value. Many of us will recall one of the earliest recommendation from the Director General of the WHO during the […]